190 related articles for article (PubMed ID: 24693437)
1. Cryotherapy for primary treatment of prostate cancer: intermediate term results of a prospective study from a single institution.
Rodríguez SA; Arias Fúnez F; Bueno Bravo C; Rodríguez-Patrón Rodríguez R; Sanz Mayayo E; Palacios VH; Burgos Revilla FJ
Prostate Cancer; 2014; 2014():571576. PubMed ID: 24693437
[TBL] [Abstract][Full Text] [Related]
2. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
3. Primary cryotherapy for localized prostate cancer treatment.
Mercader C; Musquera M; Franco A; Alcaraz A; Ribal MJ
Aging Male; 2020 Dec; 23(5):1460-1466. PubMed ID: 33191831
[TBL] [Abstract][Full Text] [Related]
4. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.
Ismail M; Ahmed S; Kastner C; Davies J
BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081
[TBL] [Abstract][Full Text] [Related]
5. Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer.
Khan A; Khan AU; Siref L; Feloney M
Cureus; 2023 Apr; 15(4):e37172. PubMed ID: 37153263
[TBL] [Abstract][Full Text] [Related]
6. Salvage Cryoablation for Recurrent Prostate Cancer Following Primary External Beam Radiotherapy or Primary Cryotherapy: A Propensity Score Matched Analysis of Mid-term Oncologic and Functional Outcomes.
Campbell SP; Deivasigamani S; Arcot R; Adams ES; Orabi H; Elshafei A; Tan WP; Davis L; Wu Y; Chang A; Jones JS; Polascik TJ
Clin Genitourin Cancer; 2023 Oct; 21(5):555-562. PubMed ID: 37438234
[TBL] [Abstract][Full Text] [Related]
7. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model.
Spiess PE; Levy DA; Mouraviev V; Pisters LL; Jones JS
BJU Int; 2013 Aug; 112(4):E256-61. PubMed ID: 23469778
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose-Rate Brachytherapy Versus Cryotherapy in Low- and Intermediate-Risk Prostate Cancer.
Gestaut MM; Cai W; Vyas S; Patel BJ; Hasan SA; MunozMaldonado Y; Deb N; Swanson G
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):101-107. PubMed ID: 28586945
[TBL] [Abstract][Full Text] [Related]
9. Cryotherapy for localised prostate cancer.
Shelley M; Wilt TJ; Coles B; Mason MD
Cochrane Database Syst Rev; 2007 Jul; (3):CD005010. PubMed ID: 17636783
[TBL] [Abstract][Full Text] [Related]
10. Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data.
Tay KJ; Polascik TJ; Elshafei A; Tsivian E; Jones JS
J Endourol; 2017 Jun; 31(6):564-571. PubMed ID: 28385075
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
[TBL] [Abstract][Full Text] [Related]
12. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy.
Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H
Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004
[TBL] [Abstract][Full Text] [Related]
13. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
14. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
15. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
Deivasigamani S; Kotamarti S; Rastinehad AR; Salas RS; de la Rosette JJMCH; Lepor H; Pinto P; Ahmed HU; Gill I; Klotz L; Taneja SS; Emberton M; Lawrentschuk N; Wysock J; Feller JF; Crouzet S; Kumar M P; Seguier D; Adams ES; Michael Z; Abreu A; Jack Tay K; Ward JF; Shinohara K; Katz AE; Villers A; Chin JL; Stricker PD; Baco E; Macek P; Ahmad AE; Chiu PKF; Crawford ED; Rogers CG; Futterer JJ; Rais-Bahrami S; Robertson CN; Hadaschik B; Marra G; Valerio M; Chong KT; Kasivisvanathan V; Tan WP; Lomas D; Walz J; Guimaraes GC; Mertziotis NI; Becher E; Finelli A; Kasraeian A; Lebastchi AH; Vora A; Rosen MA; Bakir B; Arcot R; Yee S; Netsch C; Meng X; de Reijke TM; Tan YG; Regusci S; Benjamin TGR; Olivares R; Noureldin M; Bianco FJ; Sivaraman A; Kim FJ; Given RW; Dason S; Sheetz TJ; Shoji S; Schulman A; Royce P; Shah TT; Scionti S; Salomon G; Laguna P; Tourinho-Barbosa R; Aminsharifi A; Cathelineau X; Gontero P; Stabile A; Grummet J; Ledbetter L; Graton M; Stephen Jones J; Polascik TJ;
Eur Urol; 2023 Dec; 84(6):547-560. PubMed ID: 37419773
[TBL] [Abstract][Full Text] [Related]
16. Intermediate-term oncological and functional outcomes of salvage cryotherapy for the management of prostate cancer recurrence after primary brachytherapy versus primary cryotherapy: A propensity score-matched analysis.
Deivasigamani S; Orabi H; El-Shafei A; Adams ES; Kotamarti S; Aminsharifi A; Davis L; Wu Y; J SJ; Polascik TJ
Prostate; 2023 Oct; 83(14):1373-1386. PubMed ID: 37469120
[TBL] [Abstract][Full Text] [Related]
17. Prostate cryotherapy: current status.
Ritch CR; Katz AE
Curr Opin Urol; 2009 Mar; 19(2):177-81. PubMed ID: 19195130
[TBL] [Abstract][Full Text] [Related]
18. Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry.
Tay KJ; Polascik TJ; Elshafei A; Cher ML; Given RW; Mouraviev V; Ross AE; Jones JS
J Endourol; 2016 Jan; 30(1):43-8. PubMed ID: 26414656
[TBL] [Abstract][Full Text] [Related]
19. Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry.
Shah TT; Peters M; Eldred-Evans D; Miah S; Yap T; Faure-Walker NA; Hosking-Jervis F; Thomas B; Dudderidge T; Hindley RG; McCracken S; Greene D; Nigam R; Valerio M; Minhas S; Winkler M; Arya M; Ahmed HU
Eur Urol; 2019 Jul; 76(1):98-105. PubMed ID: 30638633
[TBL] [Abstract][Full Text] [Related]
20. Hemigland Cryoablation of Localized Low, Intermediate and High Risk Prostate Cancer: Oncologic and Functional Outcomes at 5 Years.
Oishi M; Gill IS; Tafuri A; Shakir A; Cacciamani GE; Iwata T; Iwata A; Ashrafi A; Park D; Cai J; Desai M; Ukimura O; Bahn DK; Abreu AL
J Urol; 2019 Dec; 202(6):1188-1198. PubMed ID: 31347953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]